tyrosine has been researched along with Brain Emboli in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Feng, L; Liu, J; Lv, CF | 1 |
Cho, YD; Han, MH; Jung, KH; Kang, HS; Kim, JE; Lee, JY; Seo, JH | 1 |
Junghans, U; Siebler, M | 1 |
Fukunaga, K; Han, F; Kasahara, J; Moriguchi, S; Sato, T; Shiota, N; Shirakura, T; Shirasaki, Y | 1 |
Fukunaga, K; Han, F | 1 |
Higman, DJ; Imray, CH; Jarvi, K; Marshall, C; Tiivas, CA; van Dellen, D | 1 |
1 review(s) available for tyrosine and Brain Emboli
Article | Year |
---|---|
[Brain embolism-induced injury of vascular endothelial cells and a novel vasoprotective drug].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Calmodulin; Endothelial Cells; Humans; Indazoles; Intracranial Embolism; Nitric Oxide Synthase Type III; Tyrosine | 2007 |
2 trial(s) available for tyrosine and Brain Emboli
Article | Year |
---|---|
Intra-arterial tirofiban infusion for thromboembolic complication during coil embolization of ruptured intracranial aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Comorbidity; Embolization, Therapeutic; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Intracranial Aneurysm; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Prevalence; Radiography; Republic of Korea; Tirofiban; Treatment Outcome; Tyrosine | 2012 |
Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Clopidogrel; Female; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2003 |
3 other study(ies) available for tyrosine and Brain Emboli
Article | Year |
---|---|
Intra-arterial infusion of tirofiban and urokinase for thromboembolic complications during coil embolization of ruptured intracranial aneurysms.
Topics: Adult; Aged; Aneurysm, Ruptured; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Intracranial Embolism; Intracranial Thrombosis; Male; Mechanical Thrombolysis; Middle Aged; Subarachnoid Hemorrhage; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2014 |
Inhibition of nitric oxide production and protein tyrosine nitration contribute to neuroprotection by a novel calmodulin antagonist, DY-9760e, in the rat microsphere embolism.
Topics: Animals; Blotting, Western; Brain; Calmodulin; Cerebral Infarction; Indazoles; Injections, Intraperitoneal; Intracranial Embolism; Microdialysis; Microspheres; Neostriatum; Neuroprotective Agents; Nitrates; Nitric Oxide; Rats; Tyrosine | 2005 |
Transcranial Doppler ultrasonography-directed intravenous glycoprotein IIb/IIIa receptor antagonist therapy to control transient cerebral microemboli before and after carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Combined Modality Therapy; Endarterectomy, Carotid; Female; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Postoperative Complications; Preoperative Care; Tirofiban; Tyrosine; Ultrasonography, Doppler, Transcranial; Ultrasonography, Interventional | 2008 |